Effects of corticosteroid and montelukast treatment on distal lung parenchyma eosinophilic response in guinea pigs with chronic allergic inflammation Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010
Effects of corticosteroid and montelukast treatment on distal lung parenchyma and airway walls in inflammation in guinea pigs with chronic allergic inflammation Source: Annual Congress 2011 - Experimental modulation of airway inflammation Year: 2011
The effect of interferon-γ on bleomycin-induced alveolitis and pulmonary fibrosis in rats Source: Eur Respir J 2005; 26: Suppl. 49, 81s Year: 2005
Antifibrotics effects of nintedanib on lung fibroblasts derived from patients with progressive fibrosing intertitial lung diseases Source: Virtual Congress 2020 – Translational therapeutic advances Year: 2020
Evaluation of apoptosis in inflammatory cells in a model of chronic airway inflammation in guinea pigs: effects of dexamethasone and montelukast treatments Source: Eur Respir J 2003; 22: Suppl. 45, 281s Year: 2003
Effect of suplatast tosilate on bleomycin-induced lung fibrosis in mice Source: Eur Respir J 2006; 28: Suppl. 50, 305s Year: 2006
Effect of intratracheal administration of adipose-derived stromal cells on bleomycin-induced lung injury in a rat model Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015
Safety and efficacy of prolonged treatment of fibrosing alveolitis in scleroderma with cyclophosphamide Source: Eur Respir J 2005; 26: Suppl. 49, 266s Year: 2005
The histopathalogical evaluation of administration route of bleomycin in pulmonary fibrosis model and contribution of smoking to development of fibrosis Source: Annual Congress 2007 - Pathogenesis of idiopathic interstitial pneumonia including idiopathic pulmonary fibrosis Year: 2007
Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia Source: Eur Respir J 2005; 25: 528-533 Year: 2005
Olodaterol attenuates bleomycin induced lung fibrosis in mice Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action Year: 2016
Sustained PAP-reduction and tissue cGMP-restoration without systemic NO-generation by aerosolized PAPA-NONOate in an isolated lung model of acute lung injury Source: Eur Respir J 2004; 24: Suppl. 48, 561s Year: 2004
Comparative effects of inhaled and intravenous mesenchymal stem cells in bleomycin-induced pulmonary fibrosis in rabbits Source: Annual Congress 2013 –Cutting edge: drug delivery to the airways Year: 2013
Chronic lung disease in CF mouse models, role of macrophages, treatment with azithromycin Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease Year: 2009
The influence of dexamethasone on the proliferation and apoptosis of pulmonary inflammatory cells in bleomycin-induced pulmonary fibrosis in rats Source: Eur Respir J 2002; 20: Suppl. 38, 487s Year: 2002
Intravenous pulse doses of high-dose corticosteroid and cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis Source: International Congress 2015 – IPF: from bench to bedside Year: 2015
Effects of prednisolone and imatinib mesylate on inflammation and fibrosis in amiodarone-induced pulmonary toxicity in rats Source: Annual Congress 2010 - Regulation of airway pharmacology Year: 2010
Roflumilast but not methylprednisolone inhibited cigarette smoke-induced pulmonary inflammation in guinea pigs Source: Eur Respir J 2006; 28: Suppl. 50, 663s Year: 2006
Effect of nintedanib, pirfenidone, N-acetylcysteine and their combinations on cultured myofibroblast-type cells derived from patients with asbestosis and idiopathic pulmonary fibrosis Source: International Congress 2015 – Airway remodelling: recent developments Year: 2015
Therapeutic effectiveness of early and late surfactant-BL administration in bleomycine induced injury of lung in rats Source: Eur Respir J 2003; 22: Suppl. 45, 532s Year: 2003